相关实验视频

Updated: Jun 7, 2025

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice

Published on: February 9, 2014

马雷辛-1 通过调节 P38 MAPK 途径来改善败血症诱导的微质激活

Maosha Dai^1,2,3, Shujun Sun^1,2,3,4, Yan Dai^1,2,3

¹Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1277, Jiefang Avenue, Wuhan, 430022, China.

Neurochemical research

|November 20, 2024

概括

马雷辛-1 (MaR1) 通过抑制微质中的P38 MAPK通路来减少败血症诱导的神经炎症. 这项研究表明,MaR1对于与败血症相关的脑炎症具有潜在的治疗作用.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

败血症会引发危险的免疫反应,通常会导致神经炎症.
作为一种免疫调节剂的马雷辛-1 (MaR1) 可能可以治疗败血症引起的神经炎症,但其作用尚未研究.
微质细胞在败血症期间的神经炎症中发挥着关键作用.

研究的目的:

研究马雷辛-1 (MaR1) 在败血症诱导的神经炎症的治疗潜力.
探索MaR1对微质激活和P38 MAPK通路的影响.

主要方法:

采用了小鼠膜绑定和穿孔 (CLP) 败血症模型和体外脂多糖 (LPS) 诱导的BV2微质模型.
评估了微质标记物 (IBA1,CD11B,CD68,CD86,CD206) 和促炎标记物 (iNOS,COX2) 的使用情况.
使用抑制剂SB203580.0研究了P38 MAPK通路.

主要成果:

在CLP模型中,MaR1逆转了M1型微质增加.
在体外,MaR1抑制了LPS诱导的P38 MAPK核转位,并降低了iNOS和COX2的表达.
将MaR1与SB203580结合使用,与单独使用SB203580相比没有增加的治疗益处.

结论:

马雷辛-1 (MaR1) 有效地减轻了败血症引起的神经炎症.
MaR1的机制涉及抑制微质细胞中的P38 MAPK酸化.
MaR1显示出作为潜在的治疗药物治疗败血症神经炎症的承诺.

关键词:

马雷辛-1是什么意思微质细胞中的微质细胞神经炎症是一种神经炎症.败血症这是一种败血症.

更多相关视频

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Evaluation of a Reliable Biomarker in a Cecal Ligation and Puncture-Induced Mouse Model of Sepsis

Published on: December 9, 2022

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

相关概念视频

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...